(a) In the blood, Pb2+ displaces Ca2+ from the EDTA complex:
[Ca(EDTA)]2−+Pb2+→[Pb(EDTA)]2−+Ca2+
EDTA4− is a hexadentate chelating ligand: its two N and four O donor atoms wrap round a single metal ion. Pb2+ forms a more stable EDTA chelate than Ca2+ does, so the exchange goes forward. The lead ion is captured and a harmless calcium ion is released. This is an example of the chelate therapy NCERT describes, in which toxic metals are removed by forming coordination compounds.
(b) Free EDTA would chelate any metal ion it met, including the body's own Ca2+ (and Mg2+) in blood and bone. Stripping out this calcium would be dangerous. Supplied already loaded with calcium, EDTA takes up only metal ions that bind more strongly than calcium, such as Pb2+. The patient's calcium balance is therefore left undisturbed.
(c) [Pb(EDTA)]2− is a stable, soluble, charged complex that does not release Pb2+ back into the tissues. It is filtered out by the kidneys and excreted in the urine, carrying the lead out of the body.
